In a 71-year-old man with benign prostatic hyperplasia, a chronic indwelling Foley catheter, and recurrent catheter-associated urinary tract infections who recently completed levofloxacin for a Proteus urinary infection, should the Foley catheter be exchanged and a repeat urinalysis and urine culture obtained from the new catheter, and should ceftriaxone be discontinued now that his urinary symptoms have resolved?

Management of Suspected CA-UTI with Contaminated Culture

You should exchange the Foley catheter and obtain a new urine culture from the freshly placed catheter before making any treatment decisions, and discontinue ceftriaxone immediately since his symptoms have resolved and the culture shows contamination rather than true infection.

Rationale for Catheter Exchange and Repeat Culture

The IDSA guidelines explicitly state that if an indwelling catheter has been in place for ≥2 weeks at the onset of CA-UTI, the catheter should be replaced prior to antimicrobial treatment 1. This recommendation is based on Level A-I evidence showing that catheter replacement in patients with long-term catheters (≥2.5 weeks) results in:

• Significantly decreased polymicrobial bacteriuria at 28 days (p=0.02)
• Shorter time to clinical improvement at 72 hours (p<0.001)
• Lower rate of recurrent CA-UTI within 28 days (p<0.015) 1

The critical principle here is that catheter biofilms harbor bacteria that do not accurately reflect bladder infection status 1. Your current culture showing "multiple organisms with no predominant organism" is classic for contamination from catheter biofilm rather than true bladder infection 1.

Specific Steps for Culture Collection

• Replace the Foley catheter
• Obtain the urine specimen from the freshly placed catheter prior to initiating any antimicrobial therapy 1
• This provides an accurate representation of bladder flora rather than biofilm colonization

Antibiotic Management Decision

Discontinue ceftriaxone now. Here's the algorithmic reasoning:

Clinical Assessment Points:

1. Symptoms have resolved - This is your most important clinical indicator
2. Patient is clinically stable - No fever, normal vital signs implied
3. Culture shows contamination, not infection - Multiple organisms without predominance
4. Recent levofloxacin course just completed - Increases risk of resistant organisms and C. difficile

Key Distinction: CA-ASB vs CA-UTI

The guidelines strongly emphasize that screening for and treatment of catheter-associated asymptomatic bacteriuria (CA-ASB) should NOT be performed 1. The evidence shows:

• Treatment of CA-ASB does not reduce subsequent CA-UTI 1
• It increases antimicrobial resistance 1
• In one study, 47% of reinfecting organisms became highly resistant after unnecessary treatment 1

Your patient now appears to have CA-ASB (if anything), not CA-UTI, since symptoms resolved.

Common Pitfall to Avoid

The most significant error in catheterized patients is treating asymptomatic bacteriuria based on abnormal urinalysis or culture alone 1. The FDA label for ceftriaxone explicitly warns that "prescribing ceftriaxone in the absence of a proven or strongly suspected bacterial infection...increases the risk of development of drug-resistant bacteria" 2.

In your case, the initial symptoms (burning, itching, discomfort) prompted appropriate empiric therapy, but now that:

• Symptoms have resolved
• Culture is contaminated/non-diagnostic
• Patient is stable

Continuing antibiotics serves no purpose and causes harm through resistance development.

Practical Algorithm Going Forward

If symptoms recur after catheter exchange:

1. Obtain culture from new catheter
2. Initiate empiric therapy based on severity
3. Duration: 7 days if prompt symptom resolution 1
4. Consider 5-day levofloxacin for mild CA-UTI (though he just completed this) 1

If asymptomatic after catheter exchange:

1. Do not treat bacteriuria if present on repeat culture 1
2. Monitor clinically only
3. Consider whether chronic catheterization is still necessary

Duration Considerations for Future Episodes

When true CA-UTI is diagnosed, the IDSA recommends 1:

• 7 days for prompt symptom resolution (A-III evidence)
• 10-14 days for delayed response (A-III evidence)
• These durations apply regardless of whether catheter remains in place

The evidence specifically notes that microbiologic eradication is lower in catheterized patients compared to non-catheterized patients, but clinical outcomes remain acceptable with appropriate duration therapy 1.